British American Tobacco's Strategic Investment in Charlotte's Web
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 10 2024
0mins
Source: Globenewswire
British American Tobacco plc (BTI) has seen its stock price decline by 3.01%, hitting a 20-day low amid broader market gains, with the Nasdaq-100 up 0.75% and the S&P 500 up 0.51%.
The recent strategic transaction between British American Tobacco and Charlotte's Web involves converting approximately $55 million in debt into equity, which eliminates a major liability and saves $3 million in annual interest expenses. Additionally, BAT has invested $10 million in Charlotte's Web, supporting its initiatives and enhancing its financial health. This move is expected to strengthen BAT's position in the market and improve shareholder equity.
This investment reflects British American Tobacco's commitment to diversifying its portfolio and supporting innovative companies in the CBD sector. The financial restructuring is anticipated to provide Charlotte's Web with the necessary capital to expand its market presence, particularly in the healthcare sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BTI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BTI
About BTI
British American Tobacco p.l.c. is a global multi-category consumer goods business company. The Company provides tobacco and nicotine products. Its segments include the United States, Asia Pacific Middle East and Africa, and Americas and Europe. Its product categories include Vapor, Heating Products (HPs), Modern Oral, Traditional Oral, and Combustibles. Vapor products are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, known as vapor. HPs are devices that use heat to generate a nicotine-containing aerosol, which the user inhales. This category includes Tobacco Heated Products and Herbal Products for Heating (HPH). Modern Oral products are smoke-free oral nicotine products called nicotine pouches, designed for use in the mouth. Traditional oral products include snus and snuff. Its brands include Vuse, glo, Velo, Grizzly, Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, Camel, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Volatility in UK Assets Amid Political Turmoil and Investment Opportunities
- Political Turmoil Impacting Markets: The recent volatility in UK assets, particularly the 10-year gilt yield nearing post-2008 highs, reflects market uncertainty stemming from Prime Minister Keir Starmer's questioned leadership and potential challenges from rival Andy Burnham.
- Investor Optimism on Large Caps: Despite the political upheaval, Citi analysts maintain a bullish outlook on the FTSE 100, citing its significant commodity and defensive exposure as a geopolitical hedge, indicating strong investor confidence in large-cap stocks.
- Opportunities in Small Caps: Jupiter Asset Management's Adrian Gosden highlights that while small and mid-cap stocks (SMIDs) face severe challenges, identifying financially sound companies could yield substantial returns, especially given the current pessimistic market sentiment.
- Attraction of SALO Businesses: Ben Needham from Ninety One notes that the market's harsh treatment of soft asset, low obsolescence SALO businesses has created attractive investment opportunities, particularly as many companies accelerate buybacks and cash returns, signaling strong value amidst the turmoil.
See More
FENI Stock Price Analysis and ETF Dynamics
- Price Fluctuation Analysis: FENI's 52-week low is $31.80 per share, with a high of $40.8999, while the last trade was at $39.09, indicating price volatility near the high point that may influence investor buying decisions.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide useful insights for technical analysis, helping investors assess market trends and potential buy or sell opportunities.
- ETF Trading Mechanism: Exchange-traded funds (ETFs) trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on investor demand, impacting the liquidity and market performance of the ETF.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs focuses on those experiencing notable inflows (new units created) or outflows (old units destroyed), as these liquidity changes can affect the performance of individual stocks held within the ETFs.
See More
British American Tobacco Added as New Long Idea by Hedgeye
- Market Share Growth: British American Tobacco's market share in the U.S. nicotine pouch category surged from 6% at the beginning of the year to 24% by year-end, demonstrating its leadership in this rapidly growing segment and further solidifying its competitive position.
- Product Innovation Advantage: Hedgeye analyst highlighted that British American Tobacco was the first to market with a moist pouch, which has provided a competitive edge and driven rapid market share gains in the nicotine pouch category.
- FDA Authorization Impact: The FDA's recent authorization of the first fruit flavors for e-vaping marks a milestone for the industry, with British American Tobacco applying for similar age-gating technology for its Vuse vapor device, indicating potential recovery in the legal vaping market.
- Stock Price Reaction: Shares of British American Tobacco rose 1.7% on Monday, reflecting positive market sentiment regarding its growth potential, particularly in light of new product categories and market share expansion.
See More
Challenges of High-Yield Investments in Consumer Goods for 2026
- Philip Morris International: In Q1 2026, Philip Morris International reported a 9.1% year-over-year increase in net revenue to $10.1 billion, with adjusted EPS growth of 16%, and raised its full-year EPS guidance to between $8.36 and $8.51, highlighting strong growth potential in alternative tobacco products despite regulatory risks.
- British American Tobacco: British American Tobacco's Velo Plus nicotine pouches lead the rapidly growing market, with a 3.4% EPS increase for full-year 2025 and a current dividend yield of 5%, while its healthy payout ratio of 69% indicates stability despite challenges from declining combustible product volumes.
- Hormel Foods: As a
See More
Turning Point Brands Reports Strong Quarterly Sales Growth
- Sales Growth: Turning Point Brands reported net sales of $124.3 million for the quarter, reflecting a nearly 17% year-over-year increase that surpassed analyst expectations of $123.8 million, indicating strong performance in the tobacco market and solidifying its market position.
- Profitability Challenges: Despite the sales increase, non-GAAP net income fell by 11% to $14.8 million, or $0.76 per share, highlighting challenges in profitability that could impact investor confidence and market perception.
- Divergent Product Line Performance: The Stoker smokeless tobacco line saw a remarkable 48% sales increase to $87.6 million, driven by heightened demand for modern oral products, while the Zig-Zag rolling papers line experienced a 22% decline to $36.7 million, illustrating the diversity of the product portfolio and shifting market demands.
- Optimistic Future Outlook: Management raised the sales forecast for modern oral products to $210 million to $225 million for 2026, up from the previous estimate of $180 million to $190 million, which is expected to drive adjusted EBITDA to between $70 million and $90 million, reflecting the company's confidence in future growth.
See More
Trump Pressures FDA to Expedite Approval of Flavored Vapes
- Policy Pressure: President Trump is reportedly pressuring FDA Commissioner Marty Makary to expedite the approval of flavored vapes and nicotine products, highlighting the urgency of his 2024 campaign promise to appeal to younger supporters.
- Health Concerns: Despite the pressure, Makary has expressed concerns about approving fruit flavors that may appeal to children, which could lead the FDA to only approve flavors like mint, coffee, tea, and spices that are deemed more adult-oriented, thereby affecting the variety of products in the market.
- Market Impact: Should the FDA approve flavored vapes, major tobacco companies such as British American Tobacco (BTI), Altria (MO), and Philip Morris International (PM) are likely to benefit, particularly Altria through its stake in Juul and the NJOY brand.
- Financial Outlook: Altria projects an adjusted diluted EPS of $5.56 to $5.72 for 2026, indicating that the company expects to achieve a more balanced performance between the first and second halves of the year.
See More
Volatility in UK Assets Amid Political Turmoil and Investment Opportunities
- Political Turmoil Impacting Markets: The recent volatility in UK assets, particularly the 10-year gilt yield nearing post-2008 highs, reflects market uncertainty stemming from Prime Minister Keir Starmer's questioned leadership and potential challenges from rival Andy Burnham.
- Investor Optimism on Large Caps: Despite the political upheaval, Citi analysts maintain a bullish outlook on the FTSE 100, citing its significant commodity and defensive exposure as a geopolitical hedge, indicating strong investor confidence in large-cap stocks.
- Opportunities in Small Caps: Jupiter Asset Management's Adrian Gosden highlights that while small and mid-cap stocks (SMIDs) face severe challenges, identifying financially sound companies could yield substantial returns, especially given the current pessimistic market sentiment.
- Attraction of SALO Businesses: Ben Needham from Ninety One notes that the market's harsh treatment of soft asset, low obsolescence SALO businesses has created attractive investment opportunities, particularly as many companies accelerate buybacks and cash returns, signaling strong value amidst the turmoil.
See More
FENI Stock Price Analysis and ETF Dynamics
- Price Fluctuation Analysis: FENI's 52-week low is $31.80 per share, with a high of $40.8999, while the last trade was at $39.09, indicating price volatility near the high point that may influence investor buying decisions.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide useful insights for technical analysis, helping investors assess market trends and potential buy or sell opportunities.
- ETF Trading Mechanism: Exchange-traded funds (ETFs) trade similarly to stocks, where investors are buying and selling 'units' that can be created or destroyed based on investor demand, impacting the liquidity and market performance of the ETF.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs focuses on those experiencing notable inflows (new units created) or outflows (old units destroyed), as these liquidity changes can affect the performance of individual stocks held within the ETFs.
See More
British American Tobacco Added as New Long Idea by Hedgeye
- Market Share Growth: British American Tobacco's market share in the U.S. nicotine pouch category surged from 6% at the beginning of the year to 24% by year-end, demonstrating its leadership in this rapidly growing segment and further solidifying its competitive position.
- Product Innovation Advantage: Hedgeye analyst highlighted that British American Tobacco was the first to market with a moist pouch, which has provided a competitive edge and driven rapid market share gains in the nicotine pouch category.
- FDA Authorization Impact: The FDA's recent authorization of the first fruit flavors for e-vaping marks a milestone for the industry, with British American Tobacco applying for similar age-gating technology for its Vuse vapor device, indicating potential recovery in the legal vaping market.
- Stock Price Reaction: Shares of British American Tobacco rose 1.7% on Monday, reflecting positive market sentiment regarding its growth potential, particularly in light of new product categories and market share expansion.
See More
Challenges of High-Yield Investments in Consumer Goods for 2026
- Philip Morris International: In Q1 2026, Philip Morris International reported a 9.1% year-over-year increase in net revenue to $10.1 billion, with adjusted EPS growth of 16%, and raised its full-year EPS guidance to between $8.36 and $8.51, highlighting strong growth potential in alternative tobacco products despite regulatory risks.
- British American Tobacco: British American Tobacco's Velo Plus nicotine pouches lead the rapidly growing market, with a 3.4% EPS increase for full-year 2025 and a current dividend yield of 5%, while its healthy payout ratio of 69% indicates stability despite challenges from declining combustible product volumes.
- Hormel Foods: As a
See More
Turning Point Brands Reports Strong Quarterly Sales Growth
- Sales Growth: Turning Point Brands reported net sales of $124.3 million for the quarter, reflecting a nearly 17% year-over-year increase that surpassed analyst expectations of $123.8 million, indicating strong performance in the tobacco market and solidifying its market position.
- Profitability Challenges: Despite the sales increase, non-GAAP net income fell by 11% to $14.8 million, or $0.76 per share, highlighting challenges in profitability that could impact investor confidence and market perception.
- Divergent Product Line Performance: The Stoker smokeless tobacco line saw a remarkable 48% sales increase to $87.6 million, driven by heightened demand for modern oral products, while the Zig-Zag rolling papers line experienced a 22% decline to $36.7 million, illustrating the diversity of the product portfolio and shifting market demands.
- Optimistic Future Outlook: Management raised the sales forecast for modern oral products to $210 million to $225 million for 2026, up from the previous estimate of $180 million to $190 million, which is expected to drive adjusted EBITDA to between $70 million and $90 million, reflecting the company's confidence in future growth.
See More
Trump Pressures FDA to Expedite Approval of Flavored Vapes
- Policy Pressure: President Trump is reportedly pressuring FDA Commissioner Marty Makary to expedite the approval of flavored vapes and nicotine products, highlighting the urgency of his 2024 campaign promise to appeal to younger supporters.
- Health Concerns: Despite the pressure, Makary has expressed concerns about approving fruit flavors that may appeal to children, which could lead the FDA to only approve flavors like mint, coffee, tea, and spices that are deemed more adult-oriented, thereby affecting the variety of products in the market.
- Market Impact: Should the FDA approve flavored vapes, major tobacco companies such as British American Tobacco (BTI), Altria (MO), and Philip Morris International (PM) are likely to benefit, particularly Altria through its stake in Juul and the NJOY brand.
- Financial Outlook: Altria projects an adjusted diluted EPS of $5.56 to $5.72 for 2026, indicating that the company expects to achieve a more balanced performance between the first and second halves of the year.
See More
